Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sadiqa Mian"'
Social media use is growing globally, with a reported 3 billion active users in 2017. This medium is used increasingly in a health setting by patients (and to a limited extent, healthcare professionals) to share experiences and ask advice on medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add3ad084edf8c5763d3d62ce5258a38
https://europepmc.org/articles/PMC6166319/
https://europepmc.org/articles/PMC6166319/
Publikováno v:
Gynecological Surgery
The aim of this study was to provide a single site resource for investigators, clinicians, and others seeking preclinical, animal, and human investigational studies concerning the postsurgical, anti-adhesion barrier Seprafilm™ (Genzyme Corporation,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2025b26820c794bcbc8a394d0cf9a8f7
https://doi.org/10.1007/s10397-012-0741-9
https://doi.org/10.1007/s10397-012-0741-9
Publikováno v:
Gynecological Surgery
This study seeks to provide a review of the clinical data published as of July 2011 concerning the postsurgical adhesion barrier, Seprafilm (chemically modified hyaluronic acid and carboxymethylcelulose; Genzyme Corporation, Cambridge, MA). Included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b500cfae03d10b013ea9501d4074391f
https://doi.org/10.1007/s10397-012-0742-8
https://doi.org/10.1007/s10397-012-0742-8
Autor:
Diamond, Michael1 mdiamond@med.wayne.edu, Burns, Ellen2, Accomando, Beverly2, Mian, Sadiqa2, Holmdahl, Lena2
Publikováno v:
Gynecological Surgery. Sep2012, Vol. 9 Issue 3, p247-257. 11p.
Seprafilm® adhesion barrier: (1) a review of preclinical, animal, and human investigational studies.
Autor:
Diamond, Michael1 mdiamond@med.wayne.edu, Burns, Ellen2, Accomando, Beverly2, Mian, Sadiqa2, Holmdahl, Lena2
Publikováno v:
Gynecological Surgery. Sep2012, Vol. 9 Issue 3, p237-245. 9p.
Autor:
Rees S; Global Patient Safety & Labelling, Amgen Ltd, 240 Cambridge Science Park, Milton Road, Cambridge, CB4 0WD, UK., Mian S; Global Patient Safety & Labelling, Amgen Inc. Thousand Oaks, California USA., Grabowski N; Global Patient Safety & Labelling, Amgen Inc. Thousand Oaks, California USA.
Publikováno v:
Therapeutic advances in drug safety [Ther Adv Drug Saf] 2018 Aug 09; Vol. 9 (10), pp. 591-599. Date of Electronic Publication: 2018 Aug 09 (Print Publication: 2018).